JP2018514209A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018514209A5 JP2018514209A5 JP2017555767A JP2017555767A JP2018514209A5 JP 2018514209 A5 JP2018514209 A5 JP 2018514209A5 JP 2017555767 A JP2017555767 A JP 2017555767A JP 2017555767 A JP2017555767 A JP 2017555767A JP 2018514209 A5 JP2018514209 A5 JP 2018514209A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- signal peptide
- acid construct
- cell
- hydrophobic amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1507108.7 | 2015-04-27 | ||
| GBGB1507108.7A GB201507108D0 (en) | 2015-04-27 | 2015-04-27 | Nucleic acid construct |
| PCT/GB2016/051165 WO2016174409A1 (en) | 2015-04-27 | 2016-04-26 | Nucleic acid construct |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020117041A Division JP2020182473A (ja) | 2015-04-27 | 2020-07-07 | 核酸構築物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018514209A JP2018514209A (ja) | 2018-06-07 |
| JP2018514209A5 true JP2018514209A5 (enExample) | 2019-04-11 |
| JP6836516B2 JP6836516B2 (ja) | 2021-03-03 |
Family
ID=53488690
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017555767A Active JP6836516B2 (ja) | 2015-04-27 | 2016-04-26 | 核酸構築物 |
| JP2020117041A Withdrawn JP2020182473A (ja) | 2015-04-27 | 2020-07-07 | 核酸構築物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020117041A Withdrawn JP2020182473A (ja) | 2015-04-27 | 2020-07-07 | 核酸構築物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11613559B2 (enExample) |
| EP (1) | EP3288582B1 (enExample) |
| JP (2) | JP6836516B2 (enExample) |
| CN (1) | CN107532175A (enExample) |
| AU (1) | AU2016254499A1 (enExample) |
| CA (1) | CA2983687A1 (enExample) |
| ES (1) | ES2869971T3 (enExample) |
| GB (1) | GB201507108D0 (enExample) |
| HK (1) | HK1243958A1 (enExample) |
| WO (1) | WO2016174409A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3805371A1 (en) | 2014-05-15 | 2021-04-14 | National University of Singapore | Modified natural killer cells and uses thereof |
| MX2019011570A (es) | 2017-03-27 | 2019-11-18 | Nat Univ Singapore | Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales. |
| CN117363636A (zh) | 2017-03-27 | 2024-01-09 | 新加坡国立大学 | 一种编码嵌合受体的多核苷酸 |
| WO2019025800A1 (en) * | 2017-08-02 | 2019-02-07 | Autolus Limited | CELLS EXPRESSING A CHIMERIC ANTIGENIC RECEPTOR OR A MANIPULATED TCR AND COMPRISING A SELECTIVELY EXPRESSED SELECTIVE NUCLEOTIDE SEQUENCE |
| JP7360174B2 (ja) | 2018-02-09 | 2023-10-12 | ナショナル ユニヴァーシティー オブ シンガポール | ナチュラルキラー細胞免疫療法における活性化キメラ受容体及びその使用 |
| US12441787B2 (en) | 2018-04-02 | 2025-10-14 | National University Of Singapore | Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells |
| GB201805918D0 (en) | 2018-04-10 | 2018-05-23 | Autolus Ltd | Cell |
| GB201812474D0 (en) * | 2018-07-31 | 2018-09-12 | Autolus Ltd | Nucleic acid construct |
| WO2020044239A1 (en) | 2018-08-29 | 2020-03-05 | National University Of Singapore | A method to specifically stimulate survival and expansion of genetically-modified immune cells |
| CN113226340A (zh) | 2018-11-26 | 2021-08-06 | 恩卡尔塔公司 | 同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途 |
| KR20210137085A (ko) | 2019-03-05 | 2021-11-17 | 엔카르타, 인크. | Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도 |
| GB201914611D0 (en) | 2019-10-09 | 2019-11-20 | Autolus Ltd | Engineered immune cell |
| GB202007044D0 (en) | 2020-05-13 | 2020-06-24 | Autolus Ltd | Method |
| JP2022072823A (ja) | 2020-10-30 | 2022-05-17 | 藤森工業株式会社 | 包装袋 |
| TW202241935A (zh) | 2020-12-18 | 2022-11-01 | 美商世紀治療股份有限公司 | 具有可調適受體專一性之嵌合抗原受體系統 |
| GB202108184D0 (en) | 2021-06-08 | 2021-07-21 | Autolus Ltd | Engineered immune cell |
| WO2023139360A1 (en) | 2022-01-19 | 2023-07-27 | Autolus Limited | Nucleic acid construct |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002541845A (ja) | 1999-04-16 | 2002-12-10 | セルテック セラピューティックス リミテッド | 合成膜貫通成分 |
| CN101595228A (zh) * | 2005-07-21 | 2009-12-02 | 艾博特公司 | 包括sorf构建体的多基因表达和使用多蛋白、前体蛋白和蛋白酶解的方法 |
| KR101968766B1 (ko) * | 2009-11-05 | 2019-04-12 | 제넨테크, 인크. | 이종 폴리펩티드의 분비를 위한 방법 및 조성물 |
| CN103483452B (zh) | 2012-06-12 | 2021-08-13 | 上海细胞治疗集团有限公司 | 双信号独立的嵌合抗原受体及其用途 |
| GB201317929D0 (en) | 2013-10-10 | 2013-11-27 | Ucl Business Plc | Chimeric antigen receptor |
| EP3858379A1 (en) | 2013-11-21 | 2021-08-04 | Autolus Limited | Cell |
| GB201507104D0 (en) | 2015-04-27 | 2015-06-10 | Ucl Business Plc | Nucleic acid construct |
-
2015
- 2015-04-27 GB GBGB1507108.7A patent/GB201507108D0/en not_active Ceased
-
2016
- 2016-04-26 JP JP2017555767A patent/JP6836516B2/ja active Active
- 2016-04-26 EP EP16720484.1A patent/EP3288582B1/en active Active
- 2016-04-26 CA CA2983687A patent/CA2983687A1/en not_active Abandoned
- 2016-04-26 WO PCT/GB2016/051165 patent/WO2016174409A1/en not_active Ceased
- 2016-04-26 CN CN201680022736.6A patent/CN107532175A/zh active Pending
- 2016-04-26 ES ES16720484T patent/ES2869971T3/es active Active
- 2016-04-26 US US15/568,862 patent/US11613559B2/en active Active
- 2016-04-26 AU AU2016254499A patent/AU2016254499A1/en not_active Abandoned
- 2016-04-26 HK HK18103620.2A patent/HK1243958A1/zh unknown
-
2020
- 2020-07-07 JP JP2020117041A patent/JP2020182473A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2869971T3 (es) | Construcción de ácido nucleico | |
| Tucker et al. | Mouse immunoglobulin D: messenger RNA and genomic DNA sequences | |
| JP2018514208A5 (enExample) | ||
| JP2017512063A5 (enExample) | ||
| EP3601367B1 (en) | Chimeric molecules and uses thereof | |
| JP2017509335A5 (enExample) | ||
| Kinney et al. | Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins | |
| Timmins et al. | Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4 | |
| Kirchhausen et al. | Linking cargo to vesicle formation: receptor tail interactions with coat proteins | |
| JP2014506790A5 (enExample) | ||
| JP2005120106A5 (enExample) | ||
| RU2013140685A (ru) | ВАРИАНТЫ Fc, СПОСОБЫ ИХ ПОЛУЧЕНИЯ | |
| JP2020529841A5 (enExample) | ||
| IL278014B2 (en) | Anti-myostatin antibodies, polypeptides containing variable FC regions and methods of use | |
| JP2017514522A5 (enExample) | ||
| JP2015514811A5 (enExample) | ||
| JP2016501535A5 (enExample) | ||
| JP2019516665A5 (enExample) | ||
| JP2019521643A5 (enExample) | ||
| RU2017132978A (ru) | Химерный рецептор антигена | |
| CN106928320B (zh) | 一种合成Etelcalcetide的方法 | |
| RU2010122053A (ru) | Иммуносупрессорные полипептиды и нуклеиновые кислоты | |
| JP2017500035A5 (enExample) | ||
| WO2008138649A3 (en) | Signaling peptides | |
| JP2018531624A5 (enExample) |